Abstract

Background: Monocytosis (blood monocyte count > 0.8 x109/L) is relatively often observed in routine blood work from primary care, however, the significance is not always apparent as monocytosis may be present in a spectrum of diseases spanning from mild infections to chronic myelomonocytic leukemia. Aims: We aimed to examine the predictive value of monocytosis in primary care by relating monocyte count to subsequent 3-year incidence of hematological malignancy. Methods: We included 663.184 adult patients from primary care in the greater Copenhagen Area who had a complete blood cell count (CBC) performed at any time between 2000-2016. For patients with multiple samples registered, a random sample was selected and samples predating the index CBC by 3 months were assessed to account for sustained monocytosis. Using the extensive Danish health data registers, we collected data on incident hematological malignancy for 3 years following the CBC. We modelled the association between monocyte count and hematological malignancies as well as all-cause mortality using multiple logistic regression analysis. Results: Monocytosis was observed in 4,6 % of CBCs. We saw an increased risk of myeloid malignancies with the most noticeable being an odds ratio (OR) for CMML > 100 with monocytosis > 1.0 x 109/L. Sustained monocytosis increased this risk to OR >140. The incidence was, however, still low with only 0.1% of patients with monocytosis developing CMML within 3 years. Risk of lymphoproliferative and M-component related diseases were also increased, however, other relevant cell line were affected as well in these cases. Summary/Conclusion: Monocytosis is a common finding in primary care, but even with monocytosis > 1 x 109/L hematological malignancies are rare. Optimized referral to secondary care remains a challenge and if the clinical presentation leaves doubt of the diagnosis, repeated measurements help demask if malignancy is the cause of the monocytosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call